Skip to main content
Supplement ScienceSupplementScience

Types of Huperzine A: Forms & Bioavailability

Evidence:Moderate
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Forms Comparison

FormBioavailabilityBest For
Huperzine A Capsules (standardized)HighPrecise dosing — typically 50-200mcg per capsule from standardized Huperzia serrata extract
Huperzine A TabletsHighConvenient — common in nootropic stacks and combination products

Huperzine A Capsules (standardized)

Bioavailability: High. Best for: Precise dosing — typically 50-200mcg per capsule from standardized Huperzia serrata extract.

Huperzine A Tablets

Bioavailability: High. Best for: Convenient — common in nootropic stacks and combination products.

Full Huperzine A Guide

References

  1. RCTXu SS, Gao ZX, Weng Z, et al. (1999). Efficacy of tablet huperzine-A on memory, cognition, and behavior in Alzheimer's disease. Acta Pharmacologica Sinica. PubMed
  2. Meta-analysisYang G, Wang Y, Tian J, Liu JP (2013). Huperzine A for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials. PLoS ONE. DOI PubMed
  3. RCTSun QQ, Xu SS, Pan JL, et al. (1999). Huperzine-A capsules enhance memory and learning performance in 34 pairs of matched adolescent students. Acta Pharmacologica Sinica. PubMed
  4. Meta-analysisHuang P, Li B, Guo YH, Feng S, et al. (2019). [Efficacy and safety of huperzine A in treating patients with mild cognitive impairment: a systematic review and Meta-analysis].. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica. DOI PubMed
  5. Meta-analysisZheng W, Xiang YQ, Li XB, Ungvari GS, et al. (2016). Adjunctive huperzine A for cognitive deficits in schizophrenia: a systematic review and meta-analysis.. Human psychopharmacology. DOI PubMed
  6. Meta-analysisWang BS, Wang H, Wei ZH, Song YY, et al. (2009). Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer's disease: an updated meta-analysis.. Journal of neural transmission (Vienna, Austria : 1996). DOI PubMed
  7. Li J, Wu HM, Zhou RL, Liu GJ, et al. (2008). Huperzine A for Alzheimer's disease.. The Cochrane database of systematic reviews. DOI PubMed
Show 3 more references
  1. Yue J, Dong BR, Lin X, Yang M, et al. (2012). Huperzine A for mild cognitive impairment.. The Cochrane database of systematic reviews. DOI PubMed
  2. Hao Z, Liu M, Liu Z, Lv D (2009). Huperzine A for vascular dementia.. The Cochrane database of systematic reviews. DOI PubMed
  3. Wessinger CM, Inman CL, Weinstock J, Weiss EP (2021). Effect of Huperzine A on Cognitive Function and Perception of Effort during Exercise: A Randomized Double-Blind Crossover Trial.. International journal of exercise science. DOI PubMed